COST-EFFECTIVENESS ANALYSIS OF ALEMTUZUMAB FOR THE TREATMENT OF MULTIPLE SCLEROSIS IN BULGARIA, 2016

被引：0
|
作者：
Djambazov, S. [1 ]
Vekov, T. [1 ]
机构：
[1] Med Univ Pleven, Pleven, Bulgaria
来源：
VALUE IN HEALTH | 2017年 / 20卷 / 05期
关键词：
D O I：
暂无
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
PND31
引用
收藏
页码：A193 / A193
页数：1
相关论文
共 50 条
  • [21] Cost-Effectiveness Analysis of Ofatumumab for the Treatment of Relapsing-Remitting Multiple Sclerosis in Canada
    Baharnoori, Moogeh
    Bhan, Virender
    Clift, Fraser
    Thomas, Kimberly
    Mouallif, Soukaina
    Adlard, Nicholas
    Cooney, Philip
    Blanchette, Francois
    Patel, Barkha P.
    Grima, Daniel
    PHARMACOECONOMICS-OPEN, 2022, 6 (06) : 859 - 870
  • [22] Cost-effectiveness of cladribine tablets, alemtuzumab, and natalizumab in the treatment of relapsing-remitting multiple sclerosis with high disease activity in England
    Hettle, Robert
    Harty, Gerard
    Wong, Schiffon L.
    JOURNAL OF MEDICAL ECONOMICS, 2018, 21 (07) : 676 - 686
  • [23] Cost-effectiveness of treatment intervention in prediabetic patients in Bulgaria
    Yordanova, Stanislava
    Mitov, Konstantin
    Kamusheva, Maria
    PHARMACIA, 2023, 70 (03) : 809 - 816
  • [24] Cost-effectiveness of ocrelizumab for treatment of Iranian patients with relapsing multiple sclerosis
    Ayati, Nayyereh
    Taheri, Saeed
    Sahraian, Mohammad Ali
    Nikfar, Shekoufeh
    CURRENT JOURNAL OF NEUROLOGY, 2021, 20 (03): : 154 - 161
  • [25] Treatment of multiple sclerosis with interferon β:: an appraisal of cost-effectiveness and quality of life
    Parkin, D
    Jacoby, A
    McNamee, P
    Miller, P
    Thomas, S
    Bates, D
    JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 2000, 68 (02): : 144 - 149
  • [26] Assessing cost-effectiveness in the management of multiple sclerosis
    Phillips, Ceri J.
    Humphreys, Ioan
    CLINICOECONOMICS AND OUTCOMES RESEARCH, 2009, 1 : 61 - 78
  • [27] COST-EFFECTIVENESS ANALYSIS OF DRUGS USED FOR THE TREATMENT OF HIGHLY ACTIVE RELAPSING MULTIPLE SCLEROSIS IN PORTUGAL
    Silverio, N.
    Fonseca, A.
    VALUE IN HEALTH, 2018, 21 : S340 - S340
  • [28] Cost-effectiveness and budget impact analysis of siponimod in the treatment of secondary progressive multiple sclerosis in Italy
    Cortesi, Paolo Angelo
    Antonazzo, Ippazio Cosimo
    Gasperini, Claudio
    Nica, Mihaela
    Ritrovato, Daniela
    Mantovani, Lorenzo Giovanni
    PLOS ONE, 2022, 17 (03):
  • [29] Cost-effectiveness analysis of current treatment of individuals with acute exacerbation of schizophrenia in Bulgaria
    Ignatova, Desislava
    Kamusheva, Maria
    Petrova, Guenka
    Onchev, Georgi
    BIOTECHNOLOGY & BIOTECHNOLOGICAL EQUIPMENT, 2019, 33 (01) : 204 - 213
  • [30] COST-EFFECTIVENESS ANALYSIS OF DIMETHYL FUMARATE IN THE TREATMENT OF RELAPSING-REMITTING MULTIPLE SCLEROSIS IN ITALY
    Mantovani, L. G.
    Furneri, G.
    Cortesi, P. A.
    Puma, E.
    Santoni, L.
    Prosperini, L.
    VALUE IN HEALTH, 2019, 22 : S740 - S741
12345